Greenwich LifeSciences, Inc.
GLSI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,789 | -$8,892 | -$7,825 | -$4,571 |
| Dep. & Amort. | $4 | $4 | $4 | $4 |
| Deferred Tax | $0 | $0 | -$1,751 | -$1,195 |
| Stock-Based Comp. | $7,253 | $2,378 | $1,744 | $661 |
| Change in WC | $1,265 | $32 | -$122 | -$385 |
| Other Non-Cash | $0 | $0 | $1,751 | $1,195 |
| Operating Cash Flow | -$7,267 | -$6,479 | -$6,200 | -$4,292 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,369 | $0 | $0 | $3,111 |
| Stock Repurch. | $0 | $0 | -$7,536 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$275 |
| Financing Cash Flow | $4,369 | $0 | -$7,536 | $2,835 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,897 | -$6,479 | -$13,736 | -$1,456 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,989 | $13,468 | $27,204 | $28,660 |
| End Cash | $4,092 | $6,989 | $13,468 | $27,204 |
| Free Cash Flow | -$7,267 | -$6,479 | -$6,200 | -$4,292 |